Health Belief Model Based Nursing Interventions on Lymphedema Prevention

• ClinicalTrials.gov Identifier: NCT04098783
• Recruitment Status: Completed
• First Posted: September 23, 2019
• Last Update Posted: September 25, 2019
• Sponsor: Ayse Cal
• Collaborator: The Scientific and Technological Research Council of Turkey
• Information provided by (Responsible Party): Ayse Cal, Dokuz Eylul University

Study Description

Brief Summary:

Aim: The study was performed to examine effects of Health Belief Model based nursing interventions given at home visits on prevention of lymphedema in women having breast surgery.

Methods: The study had an experimental design. 72 women receiving radiotherapy after breast surgery, of whom 37 formed the intervention group and 35 formed the control group. The study had an experimental design. Data were collected with a personal information questionnaire, Quick-Disabilities of the Arm, Shoulder and Hand Score (Q-DASH), European Organization for Research and Treatment of Cancer Quality of Life for Breast Cancer 23 (EORTC QLQ-BR23), Strategies Used by Patients to Promote Health (SUPPH), Arm Circumference Form at three home visits at three-month intervals.

Hypotheses of the study

1. Extremity function restrictions will be lower in the intervention group than in the control group.
2. Self-efficacy levels will be higher in the intervention group than in the control group.
3. Functions improving the quality of life will be higher in the intervention group than in the control group.
4. There will be fewer symptoms reducing the quality of life in the intervention group than in the control group.
5. The incidence of lymphedema will be lower in the intervention group than in the control group.
6. The mean cost of the intervention group at home visits, will be lower than in the control group.

What does this paper contribute?

• Nurses can play an effective role in enabling women undergoing breast surgery to acquire behavior of lymphedema prevention. This may reduce treatment costs.
• Future research should evaluate collaborative models of care in general practice aimed at improving lymphedema prevention for women undergoing breast surgery.
• Policymakers should consider introducing funding measures for breast cancer survivors by nurses.

Condition or disease	Intervention/treatment	Phase
Breast Cancer; Breast Cancer Lymphedema; Home Visit	Other: Home visit, health education	Not Applicable

Detailed Description:

Aim of the study The aim of this study was to examine effects of Health Belief Model (HBM) based nursing interventions offered at home visits on lymphedema development in women undergoing breast surgery.

Study design and setting The study had a single-blind, randomized controlled experimental design. To avoid bias, the participants were not told whether they were in the experimental or the control group. The conceptual structure of the study is given. This randomized clinical trial was based on the guidelines proposed by the Consolidated Standard of Reporting Trials - CONSORT 2010. The study was conducted at homes of patients receiving treatment for breast cancer at a hospital and living in Samsun, a city in northern part of Turkey, between May 2016 and April 2017.

Randomization An intervention group and a control group were formed by using the research randomizer software. The program used random numbers to select participants and randomly assign them to the experimental or control group (100 participants were assigned to each group). Homogeneity test showed no significant difference between the measures of the groups in Table 1 (p>.05).

Blinding of data collectors and the statistician was implemented in this randomized blinded study. Another researcher who did not know the group assignments coded the data in the computer. After statistical analysis was conducted and the research report was written, the assistant researcher explained the codes for the experimental and control group. Therefore, blinding of data collectors, statistical analysis, and report writing was provided.

Study outcomes Personal Information Questionnaire;The questionnaire, developed by the researchers, is composed of 17 questions about sociodemographic characteristics, diagnosis and treatment of breast cancer, behavior of lymphedema prevention.

Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted…by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability. Cronbach's alpha was .85 in the present study.

Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29. Cronbach's alpha of the scale was .91 in the present study.

European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was developed from European Organization for Research and Treatment of Cancer Quality of Life Scale 30 by EORTC to measure the quality of life in individuals with breast cancer. It was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life. Cronbach's alpha was .86 for the FS, .80 for the SS.

To calculate scores for the FS and the SS, the total score for the items of each scale is divided by the total number of items and the following formulae are used:FS={1-((((total score for the items)/number of items)-1)/range)}x100 and SS={(((total score for the items)/number of items)-1)/range}x100. The highest and lowest score for the items are four and one and the difference between them, that is, three, refers to range.

Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema..

Study protocol Oral informed consent was obtained from the eligible women at the initial interviews on the phone. The women who agreed to participate in the study were assigned to the groups according to the research randomizer software. The women assigned to experimental and control groups were planned first home visit and obtained written informed consent was obtained at this visits.

At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs.

At the control group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group.

Intervention Education Material;Breast Cancer Related Lymphedema Education Guide, prepared in light of the literature and revised in accordance with three experts opinions, was used at home visits. The content of the guide was directed towards supporting seriousness and sensitivity of the participants about lymphedema and created by taking account of HBM.

Home Visits;At the first home visits to the intervention group, the researcher met the participants and their families, explained the aim of the study and administered the pretests. The guide was introduced, and health education was given. Arm exercises used to prevent lymphedema were demonstrated and measurement of the arm circumference was taught. Follow-up forms were introduced and from the women were asked to do exercises as daily, make measurements as weekly, and record them in the forms day to day regularly. The arm measurements made by the researcher were included into the analysis. The participants and their families were encouraged to phone and receive counseling about things which they needed. Each home visit lasted 45 minutes on average. Three and six months after the first visit, the patients were phoned and made an appointment. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs (repeat of education, exercises and arm circumference measurement, control of follow-up forms).

At the first home visits in the control group, the researcher was introduced herself, explained the study and administered the pretests. The measurements were repeated in the third and sixth months after the first home visit. The womens in the control group were not told about the nursing interventions, given to the intervention group, during the study period in order to avoid bias. At the end of the sixth month, education and guide about prevention of lymphedema were offered to this group.

Reminders; In the intervention group was sent a message reminding behavior Sample size calculation Before initiation of the study, to achieve 80% power, 95% confidence interval and 0.05 error range, a power analysis was made with G-power software and the sample size was found to be 14 were in each groups. However, a higher number of participants was planned to be included into the study:37 formed the intervention group, 35 formed the control group. At the end of the study, a post-hoc power analysis was made by using primary outcome variables. The post-hoc power analysis score was .98 for Q-DASH, .94 for SUPPH, .67 for the function scale (FS) and .80 for the symptom scale (SS) in EORTC QLQ-BR23.

Study budget The study was supported by The Scientific and Technological Research Council of … 1002-Short Term Funding Program (number:215S656).

Data analyses Data obtained in this study were analyzed with SPSS 21.0. Multifactorial variance analysis of repeated measures was used to compare the groups in terms of dependent variables, the significance test of difference between two means to compare pretest and posttest measures, one-way variance analysis of repeated measures to compare intragroup pretest and posttest measures and t-test for dependent groups with Bonferroni correction to perform further analysis of the difference between the mean scores of the groups. Intention-to-treat (ITT) analysis was utilized to eliminate effects of dropouts from the study, to maintain randomization. To prevent bias the database were analyzed by a statistician who was independent of the study.

Costs of treatments likely to be given for lymphedema in the intervention group and the control group due to the potential incidence of this condition and HBM based nursing interventions to be offered at home visits were made. The costs of the nursing interventions included time spent by the researcher at home visits, transportation for these visits, reminders on the phone, education material and tape measure. The cost of treatment for lymphedema included costs of medical treatment of an individual with stage I/II lymphedema in upper extremities in hospital. It was based on opinions of three experts. To calculate the costs from the perspective of Social Security Institution, prices of services and materials reported in Health Services Bulletin issued in Mar 2017 were taken. The expenses directly made by the patients were determined by the mean value of prices obtained from three national firms.

Ethical aspects Ethical approval was obtained from Dokuz Eylul University (DEU) Noninterventional Clinical Research Committee (Protocol number: 2014/08-19; approval number: 248; date: 4 April 2013 970-GOA) and … State Hospitals Directorate. Oral informed consent was obtained from the women at the initial interviews on the phone and written informed consent was obtained at the first home visits. At the end of the study, nursing interventions about prevention of lymphedema were offered to the control group.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 72 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Intervention Model Description: Randomized controlled experimental design
• Masking: Single (Participant)
• Masking Description: The study had a single-blind, randomized controlled experimental design. To avoid bias, the participants were not told whether they were in the experimental or the control group.
• Primary Purpose: Prevention
• Official Title: Effects of Health Belief Model Based Nursing Interventions Offered at Home Visits on Lymphedema Prevention in Women With Breast Cancer: A Randomized Controlled Trial
• Actual Study Start Date: May 15, 2016
• Actual Primary Completion Date: April 15, 2017
• Actual Study Completion Date: July 13, 2017

Arms and Interventions

Arm	Intervention/treatment
Experimental: Nursing interventions (home visit and health education) group; Nursing interventions group: Home visit, health education At the Intervention group; the researcher made pretest (baseline measurements) before the nursing interventions at the first home visit. The researcher offered education and guide about prevention of lymphedema after the baseline measurements at the first home visit. Second and third home visits were made three and six months after the first visit. At the second and the third home visits, the measurements were repeated, and the nursing interventions were maintained in the direction of the patients' individual needs.	Other: Home visit, health education
No Intervention: No Nursing interventions group; No Nursing interventions group; the researcher administered the pretests at first home visit. The measurements were repeated in the third and sixth months after the first home visit. The researcher also given at the end of the sixth month, all of the nursing interventions, given to the intervention group, for the control group.

Outcome Measures

Primary Outcome Measures :

1. Quick-Disabilities of the Arm, Shoulder and Hand Score [ Time Frame: 6 months ]
   Quick-Disabilities of the Arm, Shoulder and Hand Score;Q-DASH is used to determine severities of disabilities in the upper extremities and benefits gained from treatment. It was adapted Turkish by Duger et al. and its cronbach's alpha was reported to be .91. It is a five-point likert scale and includes 11 questions. The score zero indicates lack of a disability and 100 the most severe disability.
2. Strategies Used by Patients to Promote Health [ Time Frame: 6 months ]
   Strategies Used by Patients to Promote Health;SUPPH is a self-report scale created by Lev and Owen to evaluate self-efficacy of individuals in development of health promotion strategies. It was adapted Turkey by Akın and its Cronbach's alpha was reported to be .92. The scale consists of 29 items. The subscale stress reduction includes the items 1-10, making decision the items 11-13, positive attitude the items 14. Each item is scored from one to five:one corresponds to very little and five very much. The lowest and the highest scores for the scale are 29 and 145 respectively. Higher scores show higher levels of self-efficacy in self-care behavior 29.
3. European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23 [ Time Frame: 6 months ]
   European Organization for Research and Treatment of Cancer Quality of Life Scale for Breast Cancer 23;EORTC QLQ-BR23 was adapted…by Demirci et al. The scale is composed of 23 items, a four-point scale and has two scales named FS and SS. Cronbach's alpha was reported to be .88 for the FS .66 for the SS. The FS has the subscales body image (items 39,40,41,42), sexual functions (items 44,45), sexual satisfaction (item 46), worry about the future (item 43). The SS has the subscales side effects of systematic treatment (items 31,32,33,34,36,37,38), breast symptoms (items 50,51,52,53), arm symptoms (items 47,48,49), worry about hair loss (item 35). The lowest and the highest scores for each scale are zero and 100 respectfully. Higher scores for the FS show a higher quality of life and higher scores for the SS indicate a poorer quality of life.
4. Arm Circumference Measurement Form [ Time Frame: 6 months ]
   Arm Circumference Measurement Form;The form was made on four different sites on both arms:at the dorsum of the hand, the wrist, and 10cm below and above of the elbow. The difference more than 2cm between circumferences of the arms was considered as significant in terms of lymphedema.

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: Female
• Gender Based Eligibility: Yes
• Gender Eligibility Description: Women with breast cancer
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Diagnosis of primary breast cancer and having stage I, II and III
• Having axillary dissection
• Not having the diagnosis of lymphedema
• Receiving radiotherapy
• Volunteering to participate in the study
• Age over 18 years
• Female
• Residing in the city

Exclusion Criteria:

• Diagnosis of bilateral breast cancer
• Open wound or infection in the upper extremities
• Musculoskeletal disorders preventing movements of the upper extremities
• Ongoing adjuvant systemic chemotherapy

Contacts and Locations

Sponsors and Collaborators

Ayse Cal

The Scientific and Technological Research Council of Turkey

Investigators

• Principal Investigator: Ayse Cal, Asst Prof; Ankara Medipol University
• Study Director: Zuhal Bahar, Prof; Koç University
• Study Chair: Ilknur Gorken, Prof; Dokuz Eylul University

  Study Documents (Full-Text)

Documents provided by Ayse Cal, Dokuz Eylul University:

Study Protocol and Statistical Analysis Plan  [PDF] July 13, 2017

More Information

• Responsible Party: Ayse Cal, Assistant Professor, Dokuz Eylul University
• ClinicalTrials.gov Identifier: NCT04098783
• Other Study ID Numbers: 04.04.2013 970-GOA
• First Posted: September 23, 2019
• Last Update Posted: September 25, 2019
• Last Verified: September 2019

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ayse Cal, Dokuz Eylul University:

Breast Cancer; Lymphedema; Health Belief Model; Nursing; Home Visit

Additional relevant MeSH terms:

Breast Neoplasms; Lymphedema; Breast Cancer Lymphedema; Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Lymphatic Diseases; Postoperative Complications; Pathologic Processes